1. Home
  2. RLMD vs SPPL Comparison

RLMD vs SPPL Comparison

Compare RLMD & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • SPPL
  • Stock Information
  • Founded
  • RLMD 2004
  • SPPL 2016
  • Country
  • RLMD United States
  • SPPL Singapore
  • Employees
  • RLMD N/A
  • SPPL N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • SPPL
  • Sector
  • RLMD Health Care
  • SPPL
  • Exchange
  • RLMD Nasdaq
  • SPPL Nasdaq
  • Market Cap
  • RLMD 11.5M
  • SPPL 11.3M
  • IPO Year
  • RLMD N/A
  • SPPL 2023
  • Fundamental
  • Price
  • RLMD $0.27
  • SPPL $0.46
  • Analyst Decision
  • RLMD Hold
  • SPPL
  • Analyst Count
  • RLMD 4
  • SPPL 0
  • Target Price
  • RLMD $4.25
  • SPPL N/A
  • AVG Volume (30 Days)
  • RLMD 517.6K
  • SPPL 681.1K
  • Earning Date
  • RLMD 05-07-2025
  • SPPL 01-01-0001
  • Dividend Yield
  • RLMD N/A
  • SPPL N/A
  • EPS Growth
  • RLMD N/A
  • SPPL N/A
  • EPS
  • RLMD N/A
  • SPPL N/A
  • Revenue
  • RLMD N/A
  • SPPL $3,470,469.00
  • Revenue This Year
  • RLMD N/A
  • SPPL N/A
  • Revenue Next Year
  • RLMD N/A
  • SPPL N/A
  • P/E Ratio
  • RLMD N/A
  • SPPL N/A
  • Revenue Growth
  • RLMD N/A
  • SPPL N/A
  • 52 Week Low
  • RLMD $0.24
  • SPPL $0.25
  • 52 Week High
  • RLMD $5.84
  • SPPL $2.10
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 35.11
  • SPPL 39.84
  • Support Level
  • RLMD $0.25
  • SPPL $0.41
  • Resistance Level
  • RLMD $0.29
  • SPPL $0.53
  • Average True Range (ATR)
  • RLMD 0.02
  • SPPL 0.08
  • MACD
  • RLMD 0.01
  • SPPL 0.01
  • Stochastic Oscillator
  • RLMD 32.11
  • SPPL 32.17

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: